In one paragraphArticle in Circulation. Heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Marie Kervella *Institute of Myology, Center of Research in Myology, Sorbonne University, Inserm, Paris, France (M.K., C.P., Z.G., F.G., A.F., A.M.).ORCID 0009-0009-1543-9044 Charlotta S Behrens *Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Germany (C.S.B., S.R.S., T.E.).ORCID 0000-0001-6698-0572 Cécile PeccateInstitute of Myology, Center of Research in Myology, Sorbonne University, Inserm, Paris, France (M.K., C.P., Z.G., F.G., A.F., A.M.).ORCID 0000-0002-4125-3616 Zoheir GuesmiaInstitute of Myology, Center of Research in Myology, Sorbonne University, Inserm, Paris, France (M.K., C.P., Z.G., F.G., A.F., A.M.).
Fiorella GrandiInstitute of Myology, Center of Research in Myology, Sorbonne University, Inserm, Paris, France (M.K., C.P., Z.G., F.G., A.F., A.M.).ORCID 0000-0002-1303-6710 Nathalie MougenotPhénotypage du petit animal, Inserm UMS28, Sorbonne University-UPMC Paris 06, Inserm, Paris, France (N.M.).ORCID 0000-0002-7707-234X Anne ForandInstitute of Myology, Center of Research in Myology, Sorbonne University, Inserm, Paris, France (M.K., C.P., Z.G., F.G., A.F., A.M.).ORCID 0000-0003-4970-2372 Azzouz CharrabiPhyMedExp, University of Montpellier, Inserm, CNRS, France (M.K., A.C., R.A., A.C.M.).
Guy BrochierFunctional Unit of Neuromuscular Pathology, Neuropathology Department, Institute of Myology, CHU Pitié-Salpêtrière, Paris, France (G.B.).
Ramaroson AndriantsitohainaPhyMedExp, University of Montpellier, Inserm, CNRS, France (M.K., A.C., R.A., A.C.M.).ORCID 0000-0002-4770-3585 Sonia R SinghInstitute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Germany (C.S.B., S.R.S., T.E.).ORCID 0000-0002-2996-7333 Thomas EschenhagenInstitute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Germany (C.S.B., S.R.S., T.E.).ORCID 0000-0003-1750-1170 Albano C Meli *PhyMedExp, University of Montpellier, Inserm, CNRS, France (M.K., A.C., R.A., A.C.M.).ORCID 0000-0002-1727-3027 Antoine Muchir *Institute of Myology, Center of Research in Myology, Sorbonne University, Inserm, Paris, France (M.K., C.P., Z.G., F.G., A.F., A.M.).ORCID 0000-0002-4780-9275 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
backgroundDilated cardiomyopathy caused by
methodsHere, we employed human induced pluripotent stem cells (hiPSCs) derived from a patient carrying a
resultsWe demonstrated that
conclusionsTaken together, our findings underscore the crucial role of Loxl2 as a therapeutic target and suggest that its inhibition could be a promising strategy to preserve cardiac function in
Indexed as
Antibodies, Monoclonal, HumanizedCardiomyopathy, DilatedExtracellular MatrixLamin Type AMyocytes, CardiacVentricular Function, LeftAmino Acid OxidoreductasesAnimalsDisease Models, AnimalHumansInduced Pluripotent Stem CellsMiceMutationMyocardial ContractionPoint MutationAmino Acid OxidoreductasesAntibodies, Monoclonal, HumanizedLamin Type ALMNA protein, humanLOXL2 protein, humanchromosomesfibrosisheart failurelaminspoint mutation
Identifiers
PMID41841259
PMCPMC13095067
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390